Skip to content

$125 Million Settlement Reached in Warner Chilcott Whistleblower Lawsuit

On October 29, 2015, pharmaceutical manufacturer Warner Chilcott agreed to plead guilty to a felony healthcare fraud scheme and to pay $125 million to resolve kickback allegations. Seeger Weiss LLP represented the two former Warner Chilcott drug sales representatives who blew the whistle and brought this historic healthcare fraud whistleblower lawsuit forward. According to the […]

October 29, 2015

health care fraud

On October 29, 2015, pharmaceutical manufacturer Warner Chilcott agreed to plead guilty to a felony healthcare fraud scheme and to pay $125 million to resolve kickback allegations. Seeger Weiss LLP represented the two former Warner Chilcott drug sales representatives who blew the whistle and brought this historic healthcare fraud whistleblower lawsuit forward.

According to the Department of Justice (DOJ), the company’s marketing scheme involved paying kickbacks to health care professionals to prescribe its drugs as well as filling out and submitting fraudulent prior authorization requests to evade Medicare and Medicaid formulary restrictions—also a violation of patients’ privacy protections under HIPAA. In addition to Warner Chilcott pleading guilty, DOJ also announced today the indictments of former company president Carl Reichel and district managers Timothy Garcia and Landon Eckles. On October 27, 2015, DOJ filed an indictment against Rita Luthra, a Massachusetts physician. In July 2015, district manager Jeffrey Podolosky also pled guilty.

“Our clients were heroic in coming forward with these allegations and assisting DOJ with its investigation,” said relators’ counsel, Seeger Weiss founding partner Stephen A. Weiss. “It’s deeply gratifying that their perseverance and dedication has resulted in these criminal indictments and the end of Warner Chilcott’s corrupt practices. They each actively cooperated with the government’s criminal investigation for many months, helping to confirm just how important and valuable the whistleblower provisions of the False Claims Act are in rooting out and bringing an end to corporate fraud.”

The civil settlement was handled by Assistant U.S. Attorneys Sonya Rao and Susan Poswistilo of Ortiz’s Civil Division and Trial Counsel Colin Huntley of the Commercial Litigation Branch of the Justice Department’s Civil Division.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

About Seeger Weiss LLP

Founded in 1999, Seeger Weiss LLP has successfully represented relators in a myriad of qui tam “whistleblower” proceedings.  A trial firm with offices in New York, New Jersey, and Philadelphia, Seeger Weiss litigates each case as if it is going to go the distance.  We are determined to level the playing field and give a voice for our clients.  The results we achieve are characteristic of our unwavering commitment to obtain justice for our clients and our belief in the system that provides for it.

Related Documents

Download Warner Chilcott Settlement Agreement
Download Carl Reichel Indictment
Download Complaint

Contact

Stephen A. Weiss
sweiss@www.seegerweiss.com
(877) 709-5531

Related News

December 1, 2022
Seeger Weiss now accepting applicants for 2023 Diversity Fellowship

Seeger Weiss LLP announced today that the application period for the firm’s 2023 Diversity Fellowship is now open. Seeger Weiss is committed to providing an inclusive, equitable workplace where team members from all backgrounds can thrive and grow. We believe that diversity makes workplaces, institutions, and our world stronger, smarter, more resilient, and more just. […]

Read More
November 11, 2022
Chris Seeger appointed co-lead counsel in In Re: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation

Seeger Weiss is proud to announce founder Chris Seeger has been appointed to serve as co-lead counsel in the In Re: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation by the honorable Judge Yvonne Gonzalez Rogers. Seeger was one of three lawyers selected to lead the multidistrict litigation pending in the Northern District of California, […]

Read More
November 4, 2022
Seeger Weiss founding partner Chris Seeger helps negotiate $10 billion agreements with Walgreens and CVS in National Prescription Opiate Litigation

Seeger Weiss founding partner Chris Seeger along with partner Jennifer Scullion helped lead the National Prescription Opiate Litigation team in negotiations with Walgreens and CVS that culminated in over $10 billion in settlement agreements to help communities across the country ravaged by the opioid epidemic. In addition to Seeger and Scullion, negotiations were led by […]

Read More